BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Mammalian target of rapamycin inhibitors
1
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM | Browse: 713 | Download: 1744
2
Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant
4/20/2017 8:08:00 PM | Browse: 1225 | Download: 2364
3
Organ transplantation and drug eluting stents: Perioperative challenges
12/14/2016 2:15:00 PM | Browse: 1008 | Download: 1448
4
Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation
3/18/2016 2:28:00 PM | Browse: 960 | Download: 1760
5
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM | Browse: 1250 | Download: 2389
6
Hepatocellular carcinoma: A comprehensive review
11/18/2015 11:12:00 AM | Browse: 1569 | Download: 2209
7
Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant
3/24/2015 5:37:00 PM | Browse: 1157 | Download: 1835
8
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM | Browse: 1126 | Download: 758
9
“Targeting” renal cell carcinoma patients with “targeted” agents: Are we there yet?
9/3/2014 10:06:00 AM | Browse: 970 | Download: 1150
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345